NCT06574750View on ClinicalTrials.gov

Effect of a New HA Filler in Correcting Nasolabial Fold

NACompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

October 16, 2021

Primary Completion Date

May 8, 2023

Study Completion Date

May 8, 2023

Conditions
Aging Problems
Interventions
DRUG

CUREAⓇ (ARIBIO, Ltd., Seoul, Republic of Korea)

Hyaluronic acid filler injection were administered into the mid-dermis of the nasolabial fold.

DRUG

JuvedermⓇ (Q-Med AB, Uppsala, Sweden)

Hyaluronic acid filler injection were administered into the mid-dermis of the nasolabial fold.

Trial Locations (1)

13620

Seoul National University Bundang Hospital, Seongnam

All Listed Sponsors
lead

Seoul National University Bundang Hospital

OTHER

NCT06574750 - Effect of a New HA Filler in Correcting Nasolabial Fold | Biotech Hunter | Biotech Hunter